Nadia Vacca, Cristian Locci, Fabiola Serra, Elena Chicconi, Mariangela V Puci, Giovanni Sotgiu, Antonio Matteo Amadu, Roberto Antonucci
INTRODUCTION: The prevalence of COVID-19 is slightly lower, and its mortality is higher in beta-thalassemia patients than in the general population. We evaluated the impact of COVID-19 in terms of incidence, clinical course, management, and specific antibody response to vaccination in a cohort of patients with beta-thalassemia major. METHODS: We retrospectively enrolled all transfusion-dependent beta-thalassemia major patients attending the Thalassemia Day Care Center of the University Hospital of Sassari, Italy, from March 1, 2020, to May 31, 2021...
February 28, 2024: Acta Haematologica